Company page
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. is a public company listed under the ticker KPTI, operating in the American market. The company has a market capitalization of approximately $206.2 million. Karyopharm focuses on developing innovative therapies for cancer and other serious diseases.
- Ticker
- KPTI
- Market cap
- $206.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major